AC Immune SA (NASDAQ: ACIU ) will receive the first milestone payment of CHF30M from Eli Lilly (NYSE: LLY ) on or before October 7, 2019. More news on: AC Immune SA, Eli Lilly and Company, Healthcare stocks news, Stocks on the move, Read more ...

Lilly to pay CHF30 million development milestone Recognizes progress in ACI-3024 Small Molecule Tau Morphomer™ development LAUSANNE, Switzerland, Sept. 20, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company, today...

Next generation Tau tracer offers potential for earlier and more accurate diagnosis in Alzheimer’s and neurodegenerative diseases The clinical milestone highlights the strength of AC Immune’s Tau pipeline, one of the broadest in the field Reflects the compelling ...